Feb 22, 2024 | Laboratory UTCBS, Research
A disease is considered rare when it affects less than 1 in 2,000 people. There are around 7,000 such diseases, affecting 3 million people in France. But most of these diseases are still shrouded in secrecy: the cause of more than half of them is unknown, which...
Feb 9, 2024 | Laboratory UTCBS
A great first day at #HYBRID2024! This morning, after an introduction by Bruno Bonnel, General Secretary for #Investment, we had the privilege of exploring new generations of vectors for gene therapy, as well as genome-editing strategies using Crispr Cas9. The round...
Feb 7, 2024 | Laboratory UTCBS, Research
#Towards widespread access to messenger RNA (mRNA) vaccines! A licensing agreement between SATT Aquitaine and Nexbiome Therapeutics has been signed to exploit an innovative technology developed by a team from the I2M research laboratory (University of Bordeaux, CNRS,...
Nov 9, 2023 | Laboratory UTCBS, Research
Here is Shanghai’s thematic ranking for “Pharmaceuticals and Pharmaceutical Sciences”. Shanghai Ranking. UPCité is ranked 3rd just behind Harvard and University College. More information on the Université Paris Cité website Global Ranking of Acad....
Nov 3, 2023 | Laboratory UTCBS, Research
Invited for this month′s cover, the researchers from UTCBS and CiTCoM from Université Paris Cité (Paris, France), as well as Materia Nova (Mons, Belgium). The image emphasizes the deep eutectic solvent preparation thanks to hydrogen bond acceptor and donor...